158 related articles for article (PubMed ID: 38307809)
1. Biofield therapies: Guidelines for reporting clinical trials.
Hammerschlag R; Sprengel ML; Baldwin AL
Complement Ther Med; 2024 Jun; 82():103011. PubMed ID: 38307809
[TBL] [Abstract][Full Text] [Related]
2. Biofield therapies: Guidelines for reporting clinical trials.
Hammerschlag R; Sprengel ML; Baldwin AL
Explore (NY); 2024; 20(2):196-205. PubMed ID: 38307816
[TBL] [Abstract][Full Text] [Related]
3. Biofield Therapies: Guidelines for Reporting Clinical Trials.
Hammerschlag R; Sprengel M; Baldwin AL
Glob Adv Integr Med Health; 2024; 13():27536130231202501. PubMed ID: 38304734
[TBL] [Abstract][Full Text] [Related]
4. Biofield Therapies: Guidelines for Reporting Clinical Trials.
Hammerschlag R; Sprengel M; Baldwin AL
J Integr Complement Med; 2024 Feb; 30(2):133-145. PubMed ID: 38300148
[TBL] [Abstract][Full Text] [Related]
5. Nontouch biofield therapy: a systematic review of human randomized controlled trials reporting use of only nonphysical contact treatment.
Hammerschlag R; Marx BL; Aickin M
J Altern Complement Med; 2014 Dec; 20(12):881-92. PubMed ID: 25181286
[TBL] [Abstract][Full Text] [Related]
6. Guidelines for Reporting Outcomes in Trial Reports: The CONSORT-Outcomes 2022 Extension.
Butcher NJ; Monsour A; Mew EJ; Chan AW; Moher D; Mayo-Wilson E; Terwee CB; Chee-A-Tow A; Baba A; Gavin F; Grimshaw JM; Kelly LE; Saeed L; Thabane L; Askie L; Smith M; Farid-Kapadia M; Williamson PR; Szatmari P; Tugwell P; Golub RM; Monga S; Vohra S; Marlin S; Ungar WJ; Offringa M
JAMA; 2022 Dec; 328(22):2252-2264. PubMed ID: 36511921
[TBL] [Abstract][Full Text] [Related]
7. The use of biofield therapies in cancer care.
Pierce B
Clin J Oncol Nurs; 2007 Apr; 11(2):253-8. PubMed ID: 17573275
[TBL] [Abstract][Full Text] [Related]
8. Guidelines for reporting pediatric and child health clinical trial protocols and reports: study protocol for SPIRIT-Children and CONSORT-Children.
Baba A; Smith M; Potter BK; Chan AW; Moher D; Offringa M
Trials; 2024 Jan; 25(1):96. PubMed ID: 38287439
[TBL] [Abstract][Full Text] [Related]
9. Improving outcome reporting in clinical trial reports and protocols: study protocol for the Instrument for reporting Planned Endpoints in Clinical Trials (InsPECT).
Butcher NJ; Monsour A; Mew EJ; Szatmari P; Pierro A; Kelly LE; Farid-Kapadia M; Chee-A-Tow A; Saeed L; Monga S; Ungar W; Terwee CB; Vohra S; Fergusson D; Askie LM; Williamson PR; Chan AW; Moher D; Offringa M
Trials; 2019 Mar; 20(1):161. PubMed ID: 30841935
[TBL] [Abstract][Full Text] [Related]
10. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
11. Recommendations and evidence for reporting items in pediatric clinical trial protocols and reports: two systematic reviews.
Clyburne-Sherin AV; Thurairajah P; Kapadia MZ; Sampson M; Chan WW; Offringa M
Trials; 2015 Sep; 16():417. PubMed ID: 26385379
[TBL] [Abstract][Full Text] [Related]
12. CONSORT-SPI 2018 Explanation and Elaboration: guidance for reporting social and psychological intervention trials.
Grant S; Mayo-Wilson E; Montgomery P; Macdonald G; Michie S; Hopewell S; Moher D;
Trials; 2018 Jul; 19(1):406. PubMed ID: 30060763
[TBL] [Abstract][Full Text] [Related]
13. Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension.
Liu X; Cruz Rivera S; Moher D; Calvert MJ; Denniston AK;
Lancet Digit Health; 2020 Oct; 2(10):e537-e548. PubMed ID: 33328048
[TBL] [Abstract][Full Text] [Related]
14. Development process of a consensus-driven CONSORT extension for randomised trials using an adaptive design.
Dimairo M; Coates E; Pallmann P; Todd S; Julious SA; Jaki T; Wason J; Mander AP; Weir CJ; Koenig F; Walton MK; Biggs K; Nicholl J; Hamasaki T; Proschan MA; Scott JA; Ando Y; Hind D; Altman DG
BMC Med; 2018 Nov; 16(1):210. PubMed ID: 30442137
[TBL] [Abstract][Full Text] [Related]
15. The adaptive designs CONSORT extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design.
Dimairo M; Pallmann P; Wason J; Todd S; Jaki T; Julious SA; Mander AP; Weir CJ; Koenig F; Walton MK; Nicholl JP; Coates E; Biggs K; Hamasaki T; Proschan MA; Scott JA; Ando Y; Hind D; Altman DG;
Trials; 2020 Jun; 21(1):528. PubMed ID: 32546273
[TBL] [Abstract][Full Text] [Related]
16. Guidelines for Reporting Outcomes in Trial Protocols: The SPIRIT-Outcomes 2022 Extension.
Butcher NJ; Monsour A; Mew EJ; Chan AW; Moher D; Mayo-Wilson E; Terwee CB; Chee-A-Tow A; Baba A; Gavin F; Grimshaw JM; Kelly LE; Saeed L; Thabane L; Askie L; Smith M; Farid-Kapadia M; Williamson PR; Szatmari P; Tugwell P; Golub RM; Monga S; Vohra S; Marlin S; Ungar WJ; Offringa M
JAMA; 2022 Dec; 328(23):2345-2356. PubMed ID: 36512367
[TBL] [Abstract][Full Text] [Related]
17. Reporting randomised trials of social and psychological interventions: the CONSORT-SPI 2018 Extension.
Montgomery P; Grant S; Mayo-Wilson E; Macdonald G; Michie S; Hopewell S; Moher D;
Trials; 2018 Jul; 19(1):407. PubMed ID: 30060754
[TBL] [Abstract][Full Text] [Related]
18. Biofield-based therapies: a systematic review of physiological effects on practitioners during healing.
Baldwin AL; Hammerschlag R
Explore (NY); 2014; 10(3):150-61. PubMed ID: 24767262
[TBL] [Abstract][Full Text] [Related]
19. Clinical Studies of Biofield Therapies: Summary, Methodological Challenges, and Recommendations.
Jain S; Hammerschlag R; Mills P; Cohen L; Krieger R; Vieten C; Lutgendorf S
Glob Adv Health Med; 2015 Nov; 4(Suppl):58-66. PubMed ID: 26665043
[TBL] [Abstract][Full Text] [Related]
20. Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): extending the CONSORT statement.
MacPherson H; Altman DG; Hammerschlag R; Li Y; Wu T; White A; Moher D;
Acupunct Med; 2010 Jun; 28(2):83-93. PubMed ID: 20615861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
